These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23206979)

  • 21. The insulin-resistant phenotype of polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L
    Fertil Steril; 2010 Aug; 94(3):1052-8. PubMed ID: 19580964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
    Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
    J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome.
    Gursoy Calan O; Calan M; Yesil Senses P; Unal Kocabas G; Ozden E; Sari KR; Kocar M; Imamoglu C; Senses YM; Bozkaya G; Bilgir O
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):910-917. PubMed ID: 27434652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.
    Skrgatic L; Baldani DP; Cerne JZ; Ferk P; Gersak K
    J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):107-12. PubMed ID: 22107839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance and cardiovascular risk factors in women with PCOS who have normal glucose tolerance test.
    Yildir IC; Kutluturk F; Tasliyurt T; Yelken BM; Acu B; Beyhan M; Erkorkmaz U; Yilmaz A
    Gynecol Endocrinol; 2013 Feb; 29(2):148-51. PubMed ID: 23127112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
    Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
    Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is hyperandrogenemia protective for fibrocystic breast disease in PCOS?
    Ozkaya E; Cakir E; Cinar M; Kara F; Baser E; Cakir C; Kucukozkan T
    Gynecol Endocrinol; 2012 Jun; 28(6):468-71. PubMed ID: 22103710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.
    Bicer M; Guler A; Unal Kocabas G; Imamoglu C; Baloglu A; Bilgir O; Yuksel A; Bozkaya G; Calan M
    Endocr Res; 2017 May; 42(2):145-153. PubMed ID: 27911121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The independent relationship of epicardial adipose tissue with carotid intima-media thickness and endothelial functions: the association of pulse wave velocity with the active facilitated arterial conduction concept.
    Kocaman SA; Durakoğlugil ME; Çetin M; Erdoğan T; Ergül E; Çanga A
    Blood Press Monit; 2013 Apr; 18(2):85-93. PubMed ID: 23388404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extra-media thickness and epicardial fat: Comparison of a novel carotid artery ultrasound index and a well-established cardiac magnetic resonance fat quantification method.
    Haberka M; Sosnowski M; Zuziak-Pruska J; Gąsior Z
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):763-70. PubMed ID: 26033393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Echocardiographic epicardial fat thickness is associated with carotid intima-media thickness in patients with metabolic syndrome.
    Sengul C; Cevik C; Ozveren O; Oduncu V; Sunbul A; Akgun T; Can MM; Semiz E; Dindar I
    Echocardiography; 2011 Sep; 28(8):853-8. PubMed ID: 21827549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
    Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperhomocysteinaemia is associated with biochemical hyperandrogenaemia in women with reproductive age.
    Lin YH; Huang SY; Hsu MI; Chang YC; Cheng CY; Hsu CS; Tzeng CR
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):314-8. PubMed ID: 24169034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ethinyl estradiol-cyproterone acetate treatment on metabolic syndrome, fat distribution and carotid intima media thickness in polycystic ovary syndrome.
    Karabulut A; Demirlenk S; Sevket O
    Gynecol Endocrinol; 2012 Apr; 28(4):245-8. PubMed ID: 21961995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of kallistatin with carotid intima-media thickness in women with polycystic ovary syndrome.
    Calan M; Guler A; Unal Kocabas G; Alarslan P; Bicer M; Imamoglu C; Yuksel A; Bozkaya G; Bilgir O
    Minerva Endocrinol; 2018 Sep; 43(3):236-245. PubMed ID: 28294594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.
    Cascella T; Palomba S; De Sio I; Manguso F; Giallauria F; De Simone B; Tafuri D; Lombardi G; Colao A; Orio F
    Hum Reprod; 2008 Jan; 23(1):153-9. PubMed ID: 18024952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular risk factors and events in women with androgen excess.
    Macut D; Antić IB; Bjekić-Macut J
    J Endocrinol Invest; 2015 Mar; 38(3):295-301. PubMed ID: 25432327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three noninvasive methods in the evaluation of subclinical cardiovascular disease in patients with acromegaly: epicardial fat thickness, aortic stiffness and serum cell adhesion molecules.
    Topaloglu O; Sayki Arslan M; Turak O; Ginis Z; Sahin M; Cebeci M; Ucan B; Cakir E; Karbek B; Ozbek M; Cakal E; Delibasi T
    Clin Endocrinol (Oxf); 2014 May; 80(5):726-34. PubMed ID: 24164445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.